Today: June 29, 2016, 8:11 pm
  
Finance

INFINITY - IPI-145, Unpartnered, Potent PI3K Inhibitor = Larger Opportunity! - new market research report published

companiesandmarkets.com
companiesandmarkets.com
INFINITY - IPI-145, Unpartnered, Potent PI3K Inhibitor = Larger Opportunity! - a new market research report on companiesandmarkets.com

 

PR-Inside.com: 2014-03-14 09:19:02
Regaining WW rights of IPI-145 (PI3K-delta, gamma isoform inhibitor, PhI/II, hematological malignancies, inflammation) from Takeda and targeting both hematologic malignancies and inflammation indication has sparked interest in Infinity Pharma (INFI).

Despite limited clinical data in hand, PC and in vitro study demonstrates competitive advantages vs. drugs in pipeline hence the licensing/acquisition chances are bright. Based on PC data, IPI-145 is more potent than Gilead´s PI3K inhibitor Idelalisib (GS1101, PhIII). In a PhI study, IPI-145 has shown rapid onset of clinical activity in CLL/SLL as mono therapy. IPI-145´s Potential not dimmed even as a 3rd/4th...

For more details, please read our report released on 13th February 2013 on INFI titled "IPI-145, Unpartnered, Potent PI3K Inhibitor = Larger Opportunity!"

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.


Press Information


Published by
Mike King
London: +44 (0) 203 086 8600
e-mail
www.companiesandmarkets.com



# 338 Words
Related Articles
 
More From Finance
New Frontier Portfolios Top Morningstar Rankings
New Frontier’s global strategic portfolios topped the Global Balanced Strategic/All-Inclusive category of the latest Morningstar ETF [..]
The Robinhood of Wall Street: No Fee [..]
The securities and exchange industry has always been known to charge high. Today your average broker has come down drastically [..]
New Frontier Portfolios Top Morningstar Rankings
Boston, April 14, 2016—New Frontier’s global strategic portfolios topped the Global Balanced Strategic category of the latest [..]
Finding an Excellent Tax Lawyer with the [..]
Sound Advice about Finding an Excellent Attorney When an individual requires legal representation, whether for an IRS tax debt [..]
First Gothenburg Bancshares to acquire Nebanco, Inc.
Denver, CO: March 24, 2016 – First Gothenburg Bancshares, Inc., the holding company for First State Bank, Gothenburg, Nebraska [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.